Skip to content

Jesse Joseph Solvason

Chief Executive Officer at Gaius Therapeutics.

Earliest Form D on file: May 2026

Filed May 14, 2026

Gaius Therapeutics

Cell therapies for autoimmune disease

Biotech, San Diego CA

Signed as Chief Executive Officer

$60K

sold of $250K offered

Form D

LinkedIn

Network

At Gaius Therapeutics

5 people